Biomea Fusion Total Debt vs. Net Income

BMEA Stock  USD 5.76  0.03  0.52%   
Considering Biomea Fusion's profitability and operating efficiency indicators, Biomea Fusion may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Biomea Fusion's ability to earn profits and add value for shareholders. At present, Biomea Fusion's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 3.07, whereas Book Value Per Share is forecasted to decline to 2.66.
For Biomea Fusion profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biomea Fusion to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biomea Fusion utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biomea Fusion's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biomea Fusion over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.01)
Return On Assets
(0.56)
Return On Equity
(1.05)
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biomea Fusion Net Income vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biomea Fusion's current stock value. Our valuation model uses many indicators to compare Biomea Fusion value to that of its competitors to determine the firm's financial worth.
Biomea Fusion is rated third in total debt category among its peers. It is rated fifth in net income category among its peers . At present, Biomea Fusion's Net Loss is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biomea Fusion's earnings, one of the primary drivers of an investment's value.

Biomea Total Debt vs. Competition

Biomea Fusion is rated third in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 85.01 Million. Biomea Fusion retains roughly 10.3 Million in total debt claiming about 12% of equities under Health Care industry.
Total debt  Revenue  Workforce  Valuation  Capitalization

Biomea Net Income vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Biomea Fusion

Total Debt

 = 

Bonds

+

Notes

 = 
10.3 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Biomea Fusion

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(117.25 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Biomea Net Income Comparison

Biomea Fusion is currently under evaluation in net income category among its peers.

Biomea Fusion Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biomea Fusion, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biomea Fusion will eventually generate negative long term returns. The profitability progress is the general direction of Biomea Fusion's change in net profit over the period of time. It can combine multiple indicators of Biomea Fusion, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-1.1 K-1.2 K
Net Interest Income8.9 M9.3 M
Interest Income8.9 M9.3 M
Operating Income-126.1 M-119.8 M
Net Loss-117.3 M-111.4 M
Income Before Tax-117.3 M-111.4 M
Total Other Income Expense Net8.9 M9.3 M
Net Loss-73.6 M-70 M
Net Loss-117.3 M-111.4 M
Income Tax Expense-1.6 M-1.5 M
Non Operating Income Net Other1.6 M1.4 M
Change To Netincome11.9 M12.5 M
Net Loss(3.44)(3.61)
Income Quality 0.82  0.96 
Net Income Per E B T 1.12  1.08 

Biomea Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biomea Fusion. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biomea Fusion position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biomea Fusion's important profitability drivers and their relationship over time.

Use Biomea Fusion in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomea Fusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will appreciate offsetting losses from the drop in the long position's value.

Biomea Fusion Pair Trading

Biomea Fusion Pair Trading Analysis

The ability to find closely correlated positions to Biomea Fusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomea Fusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomea Fusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomea Fusion to buy it.
The correlation of Biomea Fusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomea Fusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomea Fusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomea Fusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biomea Fusion position

In addition to having Biomea Fusion in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Discretionary ETFs Thematic Idea Now

Consumer Discretionary ETFs
Consumer Discretionary ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Discretionary ETFs theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Discretionary ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Biomea Fusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomea Fusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomea Fusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomea Fusion Stock:
Check out Trending Equities.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
To fully project Biomea Fusion's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biomea Fusion at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biomea Fusion's income statement, its balance sheet, and the statement of cash flows.
Potential Biomea Fusion investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Biomea Fusion investors may work on each financial statement separately, they are all related. The changes in Biomea Fusion's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biomea Fusion's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.